191 related articles for article (PubMed ID: 32179444)
1. Comparison of the Abbott Alinity m and m2000 assays for the quantification of HIV-1, HCV and HBV in clinical samples.
Mouna L; Pallier C; Proust S; Prégermain C; Roque-Afonso AM
J Clin Virol; 2020 May; 126():104331. PubMed ID: 32179444
[TBL] [Abstract][Full Text] [Related]
2. Evaluating the aptima HIV-1 quant Dx, HCV quant Dx and HBV quant assays against the Abbott HIV-1, HCV and HBV RealTime assays.
May S; Adamska E; Tang JW
J Clin Virol; 2018 Sep; 106():7-10. PubMed ID: 30007139
[TBL] [Abstract][Full Text] [Related]
3. Clinical performance of two new, fully integrated molecular platforms used for HIV-1, HBV and HCV viral load analysis, the NeuMoDx 288 and the Alinity m.
Mourik K; Boers SA; van Rijn AL; Thijssen JCP; Wessels E; Claas ECJ
J Clin Virol; 2023 Mar; 160():105376. PubMed ID: 36640531
[TBL] [Abstract][Full Text] [Related]
4. Practical approach to method verification in plasma and validation in cerebrospinal fluid under accreditation using a flexible scope in molecular virology: setting up the HIV, HBV and HCV Aptima™ Quant Dx assays.
Lefeuvre C; Pivert A; Tran CT; Lunel-Fabiani F; Ducancelle A; Le Guillou-Guillemette H
Clin Chem Lab Med; 2020 Jan; 58(2):251-260. PubMed ID: 31539347
[TBL] [Abstract][Full Text] [Related]
5. Performance evaluation of the fully automated molecular system Alinity m in a high-throughput central laboratory.
Galindo LT; Hristov AD; Gentil LG; Scarpelli L; Santiago J; Levi JE
J Clin Virol; 2021 Apr; 137():104786. PubMed ID: 33727012
[TBL] [Abstract][Full Text] [Related]
6. Performance evaluation of the QIAGEN EZ1 DSP Virus Kit with Abbott RealTime HIV-1, HBV and HCV assays.
Schneider GJ; Kuper KG; Abravaya K; Mullen CR; Schmidt M; Bunse-Grassmann A; Sprenger-Haussels M
J Clin Virol; 2009 Apr; 44(4):292-6. PubMed ID: 19286419
[TBL] [Abstract][Full Text] [Related]
7. Multicenter comparison of the new Cobas 6800 system with Cobas Ampliprep/Cobas TaqMan and Abbott RealTime for the quantification of HIV, HBV and HCV viral load.
Wirden M; Larrouy L; Mahjoub N; Todesco E; Damond F; Delagreverie H; Akhavan S; Charpentier C; Chaix ML; Descamps D; Calvez V; Marcelin AG
J Clin Virol; 2017 Nov; 96():49-53. PubMed ID: 28950186
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a new molecular assay for detection of human immunodeficiency virus type 1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA.
McCormick MK; Dockter J; Linnen JM; Kolk D; Wu Y; Giachetti C
J Clin Virol; 2006 Jul; 36(3):166-76. PubMed ID: 16427802
[TBL] [Abstract][Full Text] [Related]
9. Real-world application of the Xpert® HBV viral load assay on serum and dried blood spots.
Jackson K; Tekoaua R; Li X; Locarnini S
J Med Virol; 2021 Jun; 93(6):3707-3713. PubMed ID: 33174623
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the analytical performance of the new Abbott RealTime RT-PCRs for the quantitative detection of HCV and HIV-1 RNA.
Schutten M; Fries E; Burghoorn-Maas C; Niesters HG
J Clin Virol; 2007 Oct; 40(2):99-104. PubMed ID: 17768084
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of the results of the 2010 External Quality Control Program of the Spanish Society of Infectious Diseases and Clinical Microbiology for HIV-1, HCV, and HBV viral loads].
Orta Mira N; Serrano Mdel R; Martínez JC; Ovies MR; Poveda M; de Gopegui ER; Cardona CG
Enferm Infecc Microbiol Clin; 2011 Dec; 29 Suppl 5():8-14. PubMed ID: 22305664
[TBL] [Abstract][Full Text] [Related]
12. Investigating utilising the Alinity m platform to detect hepatitis C virus RNA in dried blood spot samples.
Goldstein EJ; Shepherd SJ; Gunson RN
J Clin Virol; 2020 Nov; 132():104647. PubMed ID: 32979769
[TBL] [Abstract][Full Text] [Related]
13. Analytical and clinical sensitivity of the Procleix Ultrio HIV-1/HCV/HBV assay in samples with a low viral load.
Katsoulidou A; Moschidis Z; Sypsa V; Chini M; Papatheodoridis GV; Tassopoulos NC; Mimidis K; Karafoulidou A; Hatzakis A
Vox Sang; 2007 Jan; 92(1):8-14. PubMed ID: 17181585
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the Abbott investigational use only RealTime hepatitis C virus (HCV) assay and comparison to the Roche TaqMan HCV analyte-specific reagent assay.
Pyne MT; Konnick EQ; Phansalkar A; Hillyard DR
J Clin Microbiol; 2009 Sep; 47(9):2872-8. PubMed ID: 19625475
[TBL] [Abstract][Full Text] [Related]
15. Multicenter Evaluation of Two Next-Generation HIV-1 Quantitation Assays, Aptima Quant Dx and Cobas 6800, in Comparison to the RealTi
Wiesmann F; Ehret R; Naeth G; Däumer M; Fuhrmann J; Kaiser R; Noah C; Obermeier M; Schalasta G; Tiemann C; Wolf E; Knechten H; Braun P
J Clin Microbiol; 2018 Oct; 56(10):. PubMed ID: 30068537
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the Alinity m HIV-1 assay for the quantification of HIV-1 RNA plasma viral load in a high-throughput molecular laboratory in South Africa.
Maree L; Krügel M; Reinhardt B; Glass AJ
J Clin Virol; 2020 Nov; 132():104644. PubMed ID: 32992087
[TBL] [Abstract][Full Text] [Related]
17. Multicenter clinical evaluation of alinity m HCV assay performance.
Chevaliez S; Onelia F; Pacenti M; Goldstein E; Galán JC; Martínez-García L; Vilas A; Glass A; Maree L; Krügel M; Ehret R; Knechten H; Braun P; Naeth G; Bonanzinga S; Jackson K; Abravaya K; Dhein J; Huang S; Joseph AM; Lucic D; Marlowe N; Palm MJ; Pfeifer K; Toolsie D; Reinhardt B; Obermeier M; Gunson R
J Clin Virol; 2020 Aug; 129():104531. PubMed ID: 32688330
[TBL] [Abstract][Full Text] [Related]
18. Rapid, random-access, and quantification of hepatitis B virus using the Cepheid Xpert HBV viral load assay.
Auzin AM; Slavenburg S; Peters C; Boland G; Rahamat-Langendoen J; Melchers WJG; Schuurman R
J Med Virol; 2021 Jun; 93(6):3999-4003. PubMed ID: 32761911
[TBL] [Abstract][Full Text] [Related]
19. Analytical performance of four molecular platforms used for HIV-1, HBV and HCV viral load determinations.
Aretzweiler G; Leuchter S; García-Álvarez M; Simon C; Marins E; Paxinos E; Canchola J; Delgado R; Frontzek A
Expert Rev Mol Diagn; 2019 Oct; 19(10):941-949. PubMed ID: 31159598
[No Abstract] [Full Text] [Related]
20. High correlation between the Roche COBAS® AmpliPrep/COBAS® TaqMan® HIV-1, v2.0 and the Abbott m2000 RealTime HIV-1 assays for quantification of viral load in HIV-1 B and non-B subtypes.
Karasi JC; Dziezuk F; Quennery L; Förster S; Reischl U; Colucci G; Schoener D; Seguin-Devaux C; Schmit JC
J Clin Virol; 2011 Nov; 52(3):181-6. PubMed ID: 21813320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
